Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 3 Life Span Considerations.

Slides:



Advertisements
Similar presentations
Drug Action Across the Life Span
Advertisements

Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 3 Life Span Considerations NDEG 26 A – Pharmacology 1 Eliza Rivera-Mitu, RN, MSN.
Drugs Used During Pregnancy & Lactation
POSOLOGY.
Copyright © 2015 Cengage Learning® Chapter 27 Drugs and Older Adults.
CHAPTER 3 Life Span Considerations
Lifespan Considerations
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Dr AZZA ELSHERBINY Assistant professor of pharmacology.
Pharmacokinetics Chapter 4.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 25 Drug Interactions.
CHAPTER 1 The Nursing Process and Drug Therapy
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 10 Drug Therapy in Pediatric Patients.
Factors Affecting Drug Activity Chapter 11 Pages
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Objectives Describe the main physiological changes that occur with aging Identify factors affecting absorption and distribution with the geriatric client.
The Nursing Process and Drug Therapy Barbara A. Kunkel, RN, MSN Office: MS 119 Phone: Office Hours: Monday & Thursday 11a-12n; 3:30-5p; 8p-8:30p.
Mosby items and derived items © 2007 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 2 Drug Action and Handling.
CHAPTER 2 Pharmacologic Principles Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 5 Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1.
Chapter 4 Foundations and Principles of Pharmacology Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1.
PHARMACOKINETICS.

Drug Therapy for Pediatric Clients Chapter 5. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Pediatric.
Pediatric Medication Administration Module D. Pediatric Classifications Age RangeClassifications < 38 weeks gestationPremature infant < 1 monthNeonate.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1 Chapter 5.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Drug Therapy for Geriatric Clients Chapter 6. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Drug.
CHLORAMPHENICOL First broad spectrum antibiotic. First broad spectrum antibiotic. Originally isolated in Originally isolated in Now produced.
PHARMACOKINETICS Part 3.
VARIABILITY IN PHARMACOKINETICS & PATIENT RESPONSE Dr. Mohd B. Makmor Bakry, Ph.D., RPh Senior Lecturer in Clinical Pharmacy Universiti Kebangsaan Malaysia.
CLINICAL PHARMACY AGE FACTORS: FEATURES OF THE RATIONAL USE OF MEDICINES.
Age ≥ 65 = increasing population growth Elderly are estimated to consume approximately 1/3 of all prescription drugs Estimate elderly use 3/4 of over-the-counter.
Copyright ©2008 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Focus on Pharmacology, First Edition By Jahangir Moini.
Chapter 6 Drug Therapy for Geriatric Clients Chapter 6.
Principles of Drug Action
Foundation Knowledge and Skills
CHAPTER 4 L. VanValkenburg, RVT, BAS Pharmacokinetics.
Drug Therapy During Pregnancy and Breast-Feeding
Drug Therapy in Pediatric Patients
Drug efficacy is questioned.. Variation in drug responses.
Copyright © 2016 by Elsevier, Inc. All rights reserved. Geropharmacology.
Copyright © 2016, 2013, 2010 by Saunders, an imprint of Elsevier Inc. All rights reserved. Chapter 9 to 11 Drug Therapy Across the Lifespan.
By : Dr. Roshini Murugupillai
Chapters 6, 8, and 9 The Nursing Process, Drug Administration Throughout the Lifespan, Psychosocial, Gender and Cultural Influences on Pharmacotherapy.
Pharmacology I Session One Pharmacological Principles.
Basic Principles: PK By: Alaina Darby.
Drug therapy in pediatric
INTRODUCTION TO NURSING PHARMACOLOGY
Pharmacokinetics: Pediatrics
Life Span Consideration
Chapter 2 Principles of Drug Action and Drug Interactions
Pharmacokinetics: Pediatrics
Drug Therapy in Pediatric Patients
FACTORS AFFECTING DRUG ACTIVITY
Factors affecting Drug Activity
Pharmacokinetics Chapter 4
Pharmacokinetics and Factors of Individual Variation
Drug Therapy for Pediatric Clients
Copyright © 2011 by Elsevier Inc. All rights reserved.
Basic Biopharmaceutics
Medication Administration for Pediatrics
Drug Therapy in Pediatric Patients
Drug Action Across the Life Span
Drug Therapy for Geriatric Clients
POLYPHARMACY.
Presentation transcript:

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 3 Life Span Considerations

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Life Span Considerations  Pregnancy  Breast-feeding  Neonatal and Pediatric  Elderly

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Pregnancy  First trimester is the period of greatest danger for drug-induced developmental defects  Drugs cross the placenta by diffusion  During the last trimester the greatest percentage of maternally absorbed drug gets to the fetus  FDA pregnancy safety categories

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Breast-feeding  Breast-fed infants are at risk for exposure to drugs consumed by the mother  Consider risk-to-benefit ratio

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Neonatal and Pediatric Considerations: Pharmacokinetics  Absorption  Gastric pH less acidic  Gastric emptying is slowed  Intramuscular absorption faster and irregular

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Neonatal and Pediatric Considerations: Pharmacokinetics (cont’d)  Distribution  The younger the person, the greater the % of total body water  Greater TBW means fat content is lower  Decreased level of protein binding  Immature blood-brain barrier—more drugs enter the brain

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Neonatal and Pediatric Considerations: Pharmacokinetics (cont’d)  Metabolism  Liver immature, does not produce enough microsomal enzymes  Older children may have increased metabolism, requiring higher doses than infants  Other factors

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Neonatal and Pediatric Considerations: Pharmacokinetics (cont’d)  Excretion  Kidney immaturity affects glomerular filtration rate and tubular secretion  Decreased perfusion rate of the kidneys may reduce excretion of drugs

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Factors Affecting Pediatric Drug Dosages  Skin is thin and permeable  Stomach lacks acid to kill bacteria  Lungs have weaker mucus barriers  Body temperatures less well regulated and dehydration occurs easily  Liver and kidneys are immature, impairing drug metabolism and excretion

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Methods of Dosage Calculation for Pediatric Patients  Body surface area method  Using the West nomogram  Body weight dosage calculations  Using mg/kg

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

Pediatric Considerations: Medication Administration  General interventions  Infants  Toddlers  Preschoolers  School-aged children  Adolescents

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. The Elderly  Elderly: older than age 65  Healthy People 2010: older than age 55  Use of OTC medications  Increased incidence of chronic illnesses  Polypharmacy

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. Physiologic Changes in the Elderly Patient  Cardiovascular  Gastrointestinal  Hepatic  Renal

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.

The Elderly: Pharmacokinetics The Elderly: Pharmacokinetics  Absorption  Gastric pH less acidic  Slowed gastric emptying  Movement through GI tract slower  Reduced blood flow to the GI tract  Reduced absorptive surface area due to flattened intestinal villi

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. The Elderly: Pharmacokinetics (cont’d)  Distribution  TBW percentages lower  Fat content increased  Decreased production of proteins by the liver, resulting in decreased protein binding of drugs (and increased circulation of free drugs)

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. The Elderly: Pharmacokinetics (cont’d)  Metabolism  Aging liver produces fewer microsomal enzymes, affecting drug metabolism  Reduced blood flow to the liver

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. The Elderly: Pharmacokinetics (cont’d)  Excretion  Decreased glomerular filtration rate  Decreased number of intact nephrons

Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. The Elderly: Problematic Medications  Analgesics, including NSAIDs  Anticoagulants  Anticholinergics  Antidepressants  Antihypertensives  Cardiac glycosides (digoxin)  Sedatives and hypnotics  Thiazide diuretics